“Soluble Tissue Factor” in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus Formation

 

 Buy Article Permissions and Reprints

Abstract

Tissue factor (TF), the main trigger of blood coagulation, is essential for normal hemostasis. Over the past 20 years, heightened intravascular levels and activity of TF have been increasingly perceived as an entity that significantly contributes to venous as well as arterial thrombosis. Various forms of the TF protein in the circulation have been described and proposed to be thrombogenic. Aside from cell and vessel wall-associated TF, several forms of non–cell-associated TF circulate in plasma and may serve as a causative factor in thrombosis. At the present time, no firm consensus exists regarding the extent, the vascular setting(s), and/or the mechanisms by which such TF forms contribute to thrombus initiation and propagation. Here, we summarize the existing paradigms and recent, sometimes paradigm-shifting findings elucidating the structural, mechanistic, and pathophysiological characteristics of plasma-borne TF.

• References

• 1 Prager NA, Abendschein DR, McKenzie CR, Eisenberg PR. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots. Circulation 1995; 92 (4) 962-967
  CrossrefPubMedGoogle Scholar
• 2 Toschi V, Gallo R, Lettino M , et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95 (3) 594-599
  CrossrefPubMedGoogle Scholar
• 3 Marmur JD, Thiruvikraman SV, Fyfe BS , et al. Identification of active tissue factor in human coronary atheroma. Circulation 1996; 94 (6) 1226-1232
  CrossrefPubMedGoogle Scholar
• 4 Key NS, Slungaard A, Dandelet L , et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998; 91 (11) 4216-4223
  PubMedGoogle Scholar
• 5 Giesen PL, Rauch U, Bohrmann B , et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999; 96 (5) 2311-2315
  CrossrefPubMedGoogle Scholar
• 6 Mallat Z, Hugel B, Ohan J, Lesèche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99 (3) 348-353
  CrossrefPubMedGoogle Scholar
• 7 Schecter AD, Spirn B, Rossikhina M , et al. Release of active tissue factor by human arterial smooth muscle cells. Circ Res 2000; 87 (2) 126-132
  CrossrefPubMedGoogle Scholar
• 8 Berckmans RJ, Nieuwland R, Böing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85 (4) 639-646
  PubMedGoogle Scholar
• 9 Joop K, Berckmans RJ, Nieuwland R , et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001; 85 (5) 810-820
  PubMedGoogle Scholar
• 10 Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW, Radder JK. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002; 106 (19) 2442-2447
  CrossrefPubMedGoogle Scholar
• 11 Shet AS, Aras O, Gupta K , et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102 (7) 2678-2683
  CrossrefPubMedGoogle Scholar
• 12 Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9 (4) 458-462
  Google Scholar
• 13 Khan MM, Hattori T, Niewiarowski S, Edmunds Jr LH, Colman RW. Truncated and microparticle-free soluble tissue factor bound to peripheral monocytes preferentially activate factor VII. Thromb Haemost 2006; 95 (3) 462-468
  PubMedGoogle Scholar
• 14 Osterud B, Bjørklid E. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin. Scand J Haematol 1982; 29 (2) 175-184
  PubMedGoogle Scholar
• 15 Muhlfelder TW, Teodorescu V, Rand J, Rosman A, Niemetz J. Human atheromatous plaque extracts induce tissue factor activity (TFa) in monocytes and also express constitutive TFa. Thromb Haemost 1999; 81 (1) 146-150
  PubMedGoogle Scholar
• 16 Chen VM, Hogg PJ. Encryption and decryption of tissue factor. J Thromb Haemost 2013; 11 (Suppl. 01) 277-284
  CrossrefPubMedGoogle Scholar
• 17 Fogelson AL, Kuharsky AL. Membrane binding-site density can modulate activation thresholds in enzyme systems. J Theor Biol 1998; 193 (1) 1-18
  CrossrefPubMedGoogle Scholar
• 18 Spicer EK, Horton R, Bloem L , et al. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A 1987; 84 (15) 5148-5152
  CrossrefPubMedGoogle Scholar
• 19 Fiore MM, Neuenschwander PF, Morrissey JH. The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa. J Biol Chem 1994; 269 (1) 143-149
  PubMedGoogle Scholar
• 20 Banner DW, D'Arcy A, Chène C , et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996; 380 (6569) 41-46
  CrossrefPubMedGoogle Scholar
• 21 Bogdanov VY, Kirk RI, Miller C , et al. Identification and characterization of murine alternatively spliced tissue factor. J Thromb Haemost 2006; 4 (1) 158-167
  PubMedGoogle Scholar
• 22 Bogdanov VY. Blood coagulation and alternative pre-mRNA splicing: an overview. Curr Mol Med 2006; 6 (8) 859-869
  CrossrefPubMedGoogle Scholar
• 23 Wang JG, Geddings JE, Aleman MM , et al. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood 2012; 119 (23) 5543-5552
  CrossrefPubMedGoogle Scholar
• 24 van den Berg YW, Osanto S, Reitsma PH, Versteeg HH. The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood 2012; 119 (4) 924-932
  CrossrefPubMedGoogle Scholar
• 25 Jakubowski JA, Zhou C, Jurcevic S , et al. A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulation. Thromb Res 2014; 133 (2) 190-195
  CrossrefPubMedGoogle Scholar
• 26 Arraud N, Linares R, Tan S , et al. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J Thromb Haemost 2014; 12 (5) 614-627
  CrossrefPubMedGoogle Scholar
• 27 Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89 (4) 1121-1132
  PubMedGoogle Scholar
• 28 Ashcroft BA, de Sonneville J, Yuana Y , et al. Determination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidics. Biomed Microdevices 2012; 14 (4) 641-649
  CrossrefPubMedGoogle Scholar
• 29 Davila M, Robles-Carrillo L, Unruh D , et al. Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation?. J Thromb Haemost 2014; 12 (2) 186-196
  CrossrefPubMedGoogle Scholar
• 30 Silberberg JM, Gordon S, Zucker S. Identification of tissue factor in two human pancreatic cancer cell lines. Cancer Res 1989; 49 (19) 5443-5447
  PubMedGoogle Scholar
• 31 Ettelaie C, Collier ME, Maraveyas A, Ettelaie R. Characterization of physical properties of tissue factor-containing microvesicles and a comparison of ultracentrifuge-based recovery procedures. J Extracell Vesicles 2014; ; doi: 10.3402/jev.v3.23592
  PubMedGoogle Scholar
• 32 Leiderman K, Fogelson A. An overview of mathematical modeling of thrombus formation under flow. Thromb Res 2014; 133 (Suppl. 01) S12-S14
  PubMedGoogle Scholar
• 33 Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005; 96 (12) 1233-1239
  CrossrefPubMedGoogle Scholar
• 34 Biró E, Sturk-Maquelin KN, Vogel GM , et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003; 1 (12) 2561-2568
  CrossrefPubMedGoogle Scholar
• 35 Owens III AP, Mackman N. Tissue factor and thrombosis: The clot starts here. Thromb Haemost 2010; 104 (3) 432-439
  Article in Thieme ConnectPubMedGoogle Scholar
• 36 Willemze R, Bradford RL, Mooberry MJ, Roubey RA, Key NS. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications. Thromb Res 2014; 133 (2) 187-189
  CrossrefPubMedGoogle Scholar
• 37 Thaler J, Koppensteiner R, Pabinger I, Ay C, Gremmel T. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year. Thromb Res 2014; 134 (5) 1093-1096
  CrossrefPubMedGoogle Scholar
• 38 Walenga JM, Kaiser PC, Prechel MM , et al. Sustained release of tissue factor following thrombosis of lower limb trauma. Clin Appl Thromb Hemost 2014; 20 (7) 678-686
  CrossrefPubMedGoogle Scholar
• 39 Ye R, Ye C, Huang Y, Liu L, Wang S. Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis. Thromb Res 2012; 130 (2) 253-258
  CrossrefPubMedGoogle Scholar
• 40 Kooiman J, den Exter PL, Kilicsoy I , et al. Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism. J Thromb Thrombolysis 2015; 40 (3) 323-330
  CrossrefPubMedGoogle Scholar
• 41 Khorana AA, Ahrendt SA, Ryan CK , et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 2007; 13 (10) 2870-2875
  CrossrefPubMedGoogle Scholar
• 42 Thaler J, Koder S, Kornek G, Pabinger I, Ay C. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation. Transl Res 2014; 163 (2) 145-150
  CrossrefPubMedGoogle Scholar
• 43 Johansson H, Lukinius A, Moberg L , et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005; 54 (6) 1755-1762
  CrossrefPubMedGoogle Scholar
• 44 Haas SL, Jesnowski R, Steiner M , et al. Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation. World J Gastroenterol 2006; 12 (30) 4843-4849
  PubMedGoogle Scholar
• 45 Hobbs JE, Zakarija A, Cundiff DL , et al. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. Thromb Res 2007; 120 (Suppl. 02) S13-S21
  CrossrefPubMedGoogle Scholar
• 46 van den Berg YW, van den Hengel LG, Myers HR , et al. Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc Natl Acad Sci U S A 2009; 106 (46) 19497-19502
  CrossrefPubMedGoogle Scholar
• 47 Unruh D, Turner K, Srinivasan R , et al. Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma. Int J Cancer 2014; 134 (1) 9-20
  CrossrefPubMedGoogle Scholar
• 48 Unruh D, Sagin F, Adam M , et al. Levels of alternatively spliced tissue factor in the plasma of patients with pancreatic cancer may help predict aggressive tumor phenotype (e-pub ahead of print). Ann Surg Oncol PMID: 25963480
  PubMedGoogle Scholar
• 49 Lind C, Flinterman LE, Enga KF , et al. Impact of incident venous thromboembolism on risk of arterial thrombotic diseases. Circulation 2014; 129 (8) 855-863
  CrossrefPubMedGoogle Scholar
• 50 Rauch U, Nemerson Y. Tissue factor, the blood, and the arterial wall. Trends Cardiovasc Med 2000; 10 (4) 139-143
  CrossrefPubMedGoogle Scholar
• 51 Himber J, Kling D, Fallon JT, Nemerson Y, Riederer MA. In situ localization of tissue factor in human thrombi. Blood 2002; 99 (11) 4249-4250
  CrossrefPubMedGoogle Scholar
• 52 Balasubramanian V, Grabowski E, Bini A, Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 2002; 100 (8) 2787-2792
  CrossrefPubMedGoogle Scholar
• 53 Camera M, Brambilla M, Facchinetti L , et al. Tissue factor and atherosclerosis: not only vessel wall-derived TF, but also platelet-associated TF. Thromb Res 2012; 129 (3) 279-284
  CrossrefPubMedGoogle Scholar
• 54 Rauch U, Bonderman D, Bohrmann B , et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000; 96 (1) 170-175
  PubMedGoogle Scholar
• 55 Del Conde I, Shrimpton CN, Thiagarajan P, López JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106 (5) 1604-1611
  CrossrefPubMedGoogle Scholar
• 56 Palmerini T, Tomasi L, Barozzi C , et al. Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction. PLoS ONE 2013; 8 (12) e81501
  CrossrefPubMedGoogle Scholar
• 57 Karnicki K, Owen WG, Miller RS, McBane II RD. Factors contributing to individual propensity for arterial thrombosis. Arterioscler Thromb Vasc Biol 2002; 22 (9) 1495-1499
  CrossrefPubMedGoogle Scholar
• 58 Clowes AW, Clowes MM, Fingerle J, Reidy MA. Regulation of smooth muscle cell growth in injured artery. J Cardiovasc Pharmacol 1989; 14 (Suppl. 06) S12-S15
  PubMedGoogle Scholar
• 59 Srinivasan R, Ozhegov E, van den Berg YW , et al. Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling. J Thromb Haemost 2011; 9 (10) 2087-2096
  CrossrefPubMedGoogle Scholar
• 60 Kocatürk B, Versteeg HH. Tissue factor-integrin interactions in cancer and thrombosis: every Jack has his Jill. J Thromb Haemost 2013; 11 (Suppl. 01) 285-293
  CrossrefPubMedGoogle Scholar
• 61 Giannarelli C, Alique M, Rodriguez DT , et al. Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling. Circulation 2014; 130 (15) 1274-1286
  CrossrefPubMedGoogle Scholar
• 62 Kocatürk B, Van den Berg YW, Tieken C , et al. Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner. Proc Natl Acad Sci U S A 2013; 110 (28) 11517-11522
  CrossrefPubMedGoogle Scholar
• 63 Eisenreich A, Zakrzewicz A, Huber K , et al. Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells. Oncol Rep 2013; 30 (1) 462-470
  PubMedGoogle Scholar
• 64 Wang J, Wang H, Guo C , et al. Mebendazole reduces vascular smooth muscle cell proliferation and neointimal formation following vascular injury in mice. PLoS ONE 2014; 9 (2) e90146
  CrossrefPubMedGoogle Scholar
• 65 Godby RC, Van Den Berg YW, Srinivasan R , et al. Nonproteolytic properties of murine alternatively spliced tissue factor: implications for integrin-mediated signaling in murine models. Mol Med 2012; 18: 771-779
  CrossrefPubMedGoogle Scholar
• 66 Borissoff JI, Heeneman S, Kilinç E , et al. Early atherosclerosis exhibits an enhanced procoagulant state. Circulation 2010; 122 (8) 821-830
  CrossrefPubMedGoogle Scholar
• 67 Unruh D, Qi X, Chu Z , et al. Antibody-based targeting of alternatively spliced tissue factor impedes the growth and aggressiveness of pancreatic ductal adenocarcinoma. J Thromb Haemost 2015; 13 (Suppl. 02) 111
  CrossrefPubMedGoogle Scholar
• 68 Gruber A. The role of the contact pathway in thrombus propagation. Thromb Res 2014; 133 (Suppl. 01) S45-S47
  PubMedGoogle Scholar
• 69 Puy C, Tucker EI, Matafonov A , et al. Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor. Blood 2015; 125 (9) 1488-1496
  CrossrefPubMedGoogle Scholar
• 70 Stavrou EX, Fang C, Merkulova A , et al. Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor. Blood 2015; 125 (4) 710-719
  CrossrefPubMedGoogle Scholar
• 71 Fareed J. Antithrombotic therapy in 2014: Making headway in anticoagulant and antiplatelet therapy. Nat Rev Cardiol 2015; 12 (2) 70-71
  CrossrefPubMedGoogle Scholar
• 72 Chandradas S, Deikus G, Tardos JG, Bogdanov VY. Antagonistic roles of four SR proteins in the biosynthesis of alternatively spliced tissue factor transcripts in monocytic cells. J Leukoc Biol 2010; 87 (1) 147-152
  CrossrefPubMedGoogle Scholar
• 73 Eisenreich A, Bogdanov VY, Zakrzewicz A , et al. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells. Circ Res 2009; 104 (5) 589-599
  CrossrefPubMedGoogle Scholar